Novartis AG/ US66987V1098 /
26/09/2024 22:10:00 | Chg. -0.82 | Volume | Bid00:49:39 | Ask00:49:39 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
115.61USD | -0.70% | 845,915 Turnover: 53.17 mill. |
114.02Bid Size: 100 | 117.25Ask Size: 100 | 228.98 bill.USD | - | - |
Assets
|
2009 IFRS in mill. USD |
2010 IFRS in mill. USD |
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 14,075 | 15,840 | 15,627 | 16,939 | 18,197 | ||||||
Intangible Assets | 22,370 | 64,923 | 31,969 | 30,331 | 27,841 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 976 | 1,117 | 1,523 | ||||||
Fixed Assets | 61,814 | 96,633 | 93,412 | 96,212 | 95,712 | ||||||
Inventories | 5,830 | 6,093 | 5,930 | 6,744 | 7,267 | ||||||
Accounts Receivable | 8,310 | 9,873 | 10,323 | 10,051 | 9,902 | ||||||
Cash and Cash Equivalents | 2,894 | 5,319 | 3,709 | 5,552 | 6,687 | ||||||
Current Assets | 33,691 | 26,685 | 24,084 | 28,004 | 30,542 | ||||||
Total Assets | 95,505 | 123,318 | 117,496 | 124,216 | 126,254 |
Liabilities
|
2009 IFRS in mill. USD |
2010 IFRS in mill. USD |
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 4,012 | 4,788 | 4,989 | 5,593 | 6,148 | ||||||
Long-term debt | 8,675 | 14,360 | 13,855 | 13,781 | 11,242 | ||||||
Liabilities to Banks | 13,988 | 22,987 | 20,229 | 19,726 | 18,018 | ||||||
Provisions | 6,223 | 9,399 | 8,467 | 9,356 | 9,363 | ||||||
Liabilities | 38,043 | 53,549 | 51,556 | 54,997 | 51,782 | ||||||
Share Capital | 957 | 957 | 1,016 | 1,001 | 1,001 | ||||||
Total Equity | 57,387 | 63,196 | 65,844 | 69,093 | 74,343 | ||||||
Minority Interests | 75 | 6,573 | 96 | 126 | 129 | ||||||
Total liabilities equity | 95,505 | 123,318 | 117,496 | 124,216 | 126,254 |
Income Statement
|
2009 IFRS in mill. USD |
2010 IFRS in mill. USD |
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 44,267 | 50,624 | 58,566 | 56,673 | 57,920 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 9,982 | 11,526 | 10,998 | 11,511 | 10,910 | ||||||
Interest Income | - | - | - | -724 | -683 | ||||||
Income Before Taxes | 9,922 | 11,702 | 10,773 | 11,243 | 10,735 | ||||||
Income Taxes | 1,468 | 1,733 | 1,528 | 1,625 | 1,443 | ||||||
Minority Interests Profit | -54 | -175 | -132 | -113 | -117 | ||||||
Net Income | 8,400 | 9,794 | 9,113 | 9,505 | 9,175 |
Per Share
Cash Flow
|
2009 IFRS in mill. USD |
2010 IFRS in mill. USD |
2011 IFRS in mill. USD |
2012 IFRS in mill. USD |
2013 IFRS in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 12,191 | 14,067 | 14,309 | 14,194 | 13,174 | ||||||
Cash Flow from Investing Activities | -14,219 | -15,756 | -792 | -5,675 | -3,352 | ||||||
Cash Flow from Financing | 2,809 | 4,116 | -15,024 | -6,675 | -8,769 | ||||||
Decrease / Increase in Cash | 856 | 2,425 | -1,610 | 1,843 | 1,135 | ||||||
Employees | 99,834 | 119,418 | 123,686 | 127,724 | 135,696 |